NVDA stock increased by 5% this week. Here’s our data analysis.
$NVDA experienced a 5% increase in its stock value this week, as reported by our data from Polygon. This surge in the stock price has captured the attention of many investors, making it the second most-searched ticker on Quiver Quantitative out of a total of 50 tickers searched over the past week.
Delving deeper into the inner workings of $NVDA, our data reveals intriguing insights into the company’s insider trading activities. Over the past six months, insiders have engaged in 511 trades involving $NVDA stock. Notably, all of these trades were sales, totaling significant amounts in shares and estimated values. For instance, JEN HSUN HUANG, the President and CEO, executed 354 sales, selling 5,625,000 shares valued at approximately $991,941,033. Similarly, other key figures within the company, such as MARK A STEVENS, HARVEY C JONES, and A BROOKE SEAWELL, have also conducted sales transactions contributing to the substantial movement of $NVDA stock in the market.
In addition to insider trading, hedge funds have played a pivotal role in shaping the landscape of $NVDA stock holdings. A total of 2,608 institutional investors added shares of $NVDA to their portfolios in the most recent quarter, while 2,493 decreased their positions. Highlighting some of the noteworthy actions taken by prominent institutions, such as KINGSTONE CAPITAL PARTNERS TEXAS, LLC, UBS AM, CLEAR STREET LLC, JPMORGAN CHASE & CO, CAPITAL RESEARCH GLOBAL INVESTORS, and BLACKROCK, INC., sheds light on the dynamic nature of hedge fund activity in relation to $NVDA.
Further exploration of $NVDA’s market interactions unveils intriguing insights into the stock trading activities of members of Congress. In the past six months, these political figures have engaged in 46 trades involving $NVDA stock, with a majority of these transactions being purchases. Notable figures like REPRESENTATIVE DWIGHT EVANS, GILBERT RAY CISNEROS JR., LISA C. MCCLAIN, CLEO FIELDS, SENATOR SHELDON WHITEHOUSE, REPRESENTATIVE VAL T. HOYLE, SENATOR JOHN BOOZMAN, and SENATOR ANGUS S. KING JR. have contributed to the buying and selling activity surrounding $NVDA in the congressional realm.
In the realm of analyst ratings, $NVDA has received favorable reports from Wall Street analysts. A total of 31 firms have issued buy ratings on the stock, signifying a positive outlook on the company’s performance. Recent ratings from firms such as Baird, B of A Securities, Bernstein, Tigress Financial, Morgan Stanley, Needham, and Benchmark highlight the consistent trend of positive sentiment toward $NVDA from these financial entities.
Moreover, a comprehensive analysis of price targets set by various analysts portrays an optimistic outlook for $NVDA. With a median target of $250.0, analysts like Stacy Rasgon, Tristan Gerra, Vivek Arya, William Stein, Ivan Feinseth, Joseph Moore, and N. Quinn Bolton have set price targets ranging from $240.0 to $350.0, indicating a bullish sentiment and potential growth opportunities for $NVDA in the foreseeable future.
This article serves as a data-driven overview of key insights derived from $NVDA’s performance in the stock market. It is essential to note that the information presented here is solely based on quantitative data and does not constitute financial advice. For more detailed analysis and real-time tracking of $NVDA data, individuals can refer to Quiver Quantitative’s platform, ensuring transparency and informed decision-making within the financial realm.